SynthesisEuropean journal of pediatrics2025
Comparison of transumbilical laparoscopic-assisted appendectomy (TULAA) vs conventional three-port laparoscopic appendectomy (CTLA) in the pediatric population: a systematic review and meta-analysis.
Synthesis in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Appendicitis, a pediatric emergency, is usually managed with conventional three-port laparoscopic appendectomy (CTLA). Transumbilical laparoscopic-assisted appendectomy (TULAA) offers a novel approach, matching the benefits of CTLA. This meta-analysis aims to evaluate the safety and effectiveness of TULAA versus CTLA in children by incorporating newly reported outcomes (ileus, readmission), providing separate analyses for complicated and uncomplicated appendicitis, and updating existing evidence. A thorough search of PubMed, Cochrane Library, Science Direct, and ClinicalTrials.gov databases was made from inception to May 2024. Studies comparing the results of TULAA and conventional three-port laparoscopic appendectomy (CTLA) in pediatric patients aged 0 to 18 years were included. The mean differences for continuous and risk ratios for dichotomous outcomes were combined using RevMan 5.4.1 software, with a 95% confidence interval using the random effects model. The Newcastle-Ottawa Scale and the Cochrane Risk of Bias Tool were used to ensure quality assessment. The funnel plots and Egger's regression test were used to assess the risk of publication bias in the included studies. This meta-analysis included 16 studies with 5084 pediatric patients. TULAA showed significantly shorter operative time (p = 0.00001), reduced hospital stay (p = 0.002), and lower intraabdominal infection rates (p = 0.03) compared to CTLA but required more additional ports (p = 0.00001). No significant differences were found in wound infection (p = 0.68), ileus (p = 0.38), conversion rate (p = 0.09), or readmission (p = 0.43). Separate analysis revealed shorter operative time with TULAA in both uncomplicated (p = 0.00001) and complicated cases (p = 0.002). Hospital stay was shorter only in uncomplicated cases (p = 0.01), while intraabdominal infections were lower in complicated cases (p = 0.01) in the TULAA group. Other outcomes remained comparable across both groups.
conclusionTULAA was superior to CTLA in operative time, hospital stay, and intraabdominal infection. Separate analysis confirmed these benefits in uncomplicated cases and demonstrated reduced intraabdominal infections in complicated cases, though with higher conversion and port use. Remaining outcomes were similar. TULAA may be a safe and effective alternative to CTLA in selected pediatric cases, especially in complicated appendicitis.
trial registrationProspero registration ID CRD42024563556. https://www.crd.york.ac.uk/PROSPERO/view/CRD42024563556 . WHAT IS KNOWN: • CTLA is the standard pediatric appendectomy procedure with established safety and efficacy. • TULAA is gaining popularity as a minimally invasive alternative, offering potential benefits. WHAT IS NEW: • The analysis highlights the efficacy of both TULAA and CTLA in overall appendicitis cases, while also offering a comparative assessment of their outcomes in complicated and uncomplicated appendicitis subgroups. • New insights into ileus and readmissions have not been previously addressed.
Indexed as
Identifiers
40560237What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.